Methodological and reporting quality of systematic reviews referenced in the clinical practice guideline for pediatric high-blood pressure

Journal of Hypertension

Volumn 37, Issue 3, 2019, Pages 488-495

  Vaughn, Kaleb ^a   Skinner, Mason ^a   Vaughn, Victoria ^a   Wayant, Cole ^a   Vassar, Matt ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Evidence based medicine; Hypertension; Pediatrics; Quality evidence; Systematic reviews

Indexed keywords

A MEASUREMENT TOOL TO ASSESS SYSTEMATIC REVIEWS; ADOLESCENT; BLOOD PRESSURE REGULATION; CHILD; CONSENSUS; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES; PRIORITY JOURNAL; REVIEW; SCREENING; SYSTEMATIC REVIEW; MEDICAL RESEARCH;

ADOLESCENT; BIOMEDICAL RESEARCH; CHILD; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC; SYSTEMATIC REVIEWS AS TOPIC;

EID: 85060924324     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001870     Document Type: Review

References (73)

1. Flynn J. The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol 2013; 28:1059-1066.
2. Friedemann C, Heneghan C, Mahtani K, Thompson M, Perera R, Ward AM. Cardiovascular disease risk in healthy children and its association with body mass index: Systematic review and meta-analysis. BMJ 2012; 345:e4759.
3. Ogden CL, Carroll MD, Lawman HG, Fryar CD, Kruszon-Moran D, Kit BK, Flegal KM. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA 2016; 315:2292-2299.
4. Oikonen M, Nuotio J, Magnussen CG, Viikari JS, Taittonen L, Laitinen T, et al. Repeated blood pressure measurements in childhood in prediction of hypertension in adulthood. Hypertension 2016; 67:41-47.
5. Shen W, Zhang T, Li S, Zhang H, Xi B, Shen H, et al. Race and sex differences of long-termblood pressure profiles from childhood and adult hypertension: The Bogalusa Heart Study. Hypertension 2017; 70:66-74.
6. Daniels SR. Adverse outcomes in pediatric hypertension. Hypertension 2017; 70:1089-1090.
7. Navarini S, Bellsham-Revell H, Chubb H, Gu H, Sinha MD, Simpson JM. Myocardial deformation measured by 3-dimensional speckle tracking in children and adolescents with systemic arterial hypertension. Hypertension 2017; 70:1142-1147.
8. Lande MB, Carson NL, Roy J, Meagher CC. Effects of childhood primary hypertension on carotid intima media thickness: A matched controlled study. Hypertension 2006; 48:40-44.
9. Sorof JM, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003; 111:61-66.
10. Shapiro DJ, Hersh AL, Cabana MD, Sutherland SM, Patel AI. Hypertension screening during ambulatory pediatric visits in the United States, 2000-2009. Pediatrics 2012; 130:604-610.
11. Stabouli S, Sideras L, Vareta G, Eustratiadou M, Printza N, Dotis J. Hypertension screening during healthcare pediatric visits. J Hypertens 2015; 33:1064-1068.
12. Moyer VA, U.S. Preventive Services Task Force. Screening for primary hypertension in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Pediatrics 2013; 132:907-914.
13. Siu AL, U.S. Preventive Services Task Force. Screening for high blood pressure in adults: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2015; 163:778-786.
14. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al., SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017; 140:; pii: E20171904.
15. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; 71:2199-2269.
16. Fleming PS, Koletsi D, Seehra J, Pandis N. Systematic reviews published in higher impact clinical journals were of higher quality. J Clin Epidemiol 2014; 67:754-759.
17. Lo T, Malaga-Dieguez L, Trachtman HUS. Preventive Services Task Force recommendation and pediatric hypertension screening: Dereliction of duty or call to arms? J Clin Hypertens 2014; 16:342-343.
18. Falkner B, Flynn J. Response to 'U.S. Preventive Services Task Force Recommendation and Pediatric Hypertension Screening: Dereliction of Duty or Call to Arms?'. J Clin Hypertens 2014; 16:344-345.
19. American Academy of Pediatrics Steering Committee on Quality Improvement and Management. Classifying Recommendations for Clinical Practice Guidelines. Pediatrics 2004; 114:874-877.
20. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016; 5:210.
21. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007; 7:10.
22. Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol 2009; 62:1013-1020.
23. Pieper D, Buechter RB, Li L, Prediger B, Eikermann M. Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties. J Clin Epidemiol 2015; 68:574-583.
24. Burda BU, Holmer HK, Norris SL. Limitations of A Measurement Tool to Assess Systematic Reviews (AMSTAR) and suggestions for improvement. Syst Rev 2016; 5:58.
25. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009; 339:b2700.
26. Summerbell CD, Ashton V, Campbell KJ, Edmunds L, Kelly S, Waters E. Interventions for treating obesity in children. Cochrane Database Syst Rev (3):2003; CD001872.
27. Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R. Pharmacological interventions for hypertension in children. Evid Based Child Health 2014; 9:498-580.
28. Li JS, Baker-Smith CM, Smith PB, Hasselblad V, Murphy MD, Califf RM, et al. Racial differences in blood pressure response to angiotensinconverting enzyme inhibitors in children: A meta-analysis. Clin Pharmacol Ther 2008; 84:315-319.
29. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: Systematic review and metaanalyses. BMJ 2013; 346:f1326.
30. Halm MA. Arm Circumference, shape, and length: How interplaying variables affect blood pressure measurement in obese persons. Am J Crit Care 2014; 23:166-170.
31. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. Obstet Gynecol Surv 2012; 67:156-158.
32. Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: A systematic review and meta-regression analysis. Circulation 2008; 117:3171-3180.
33. Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev (3):2009; CD001096.
34. Rao M, Afshin A, Singh G, Mozaffarian D. Do healthier foods and diet patterns cost more than less healthy options? A systematic review and meta-analysis. BMJ Open 2013; 3:e004277.
35. Kelley GA, Kelley KS, Tran ZV. The effects of exercise on resting blood pressure in children and adolescents: A meta-analysis of randomized controlled trials. Prev Cardiol 2003; 6:8-16.
36. Narayan H, Webb DJ. New evidence supporting the use of mineralocorticoid receptor blockers in drug-resistant hypertension. Curr Hypertens Rep 2016; 18:34.
37. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: A case study of industry documents from rofecoxib litigation. JAMA 2008; 299:1800-1812.
38. Rohwer A, Young T, Wager E, Garner P. Authorship, plagiarism and conflict of interest: Views and practices from low/middle-income country health researchers. BMJ Open 2017; 7:e018467.
39. Kesselheim AS, Robertson CT, Myers JA, Rose SL, Gillet V, Ross KM. A randomized study of how physicians interpret research funding disclosures. N Engl J Med 2012; 367:1119-1127.
40. Wegewitz U, Weikert B, Fishta A, Jacobs A, Pieper D. Resuming the discussion of AMSTAR: What can (should) be made better? BMC Med Res Methodol 2016; 16:111.
41. Dwan K, Gamble C, Williamson PR, Kirkham JJ, Reporting Bias Group. Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review. PLoS One 2013; 8:e66844.
42. Onishi A, Furukawa TA. Publication bias is underreported in systematic reviews published in high-impact-factor journals: Metaepidemiologic study. J Clin Epidemiol 2014; 67:1320-1326.
43. Atakpo P, Vassar M. Publication bias in dermatology systematic reviews and meta-analyses. J Dermatol Sci 2016; 82:69-74.
44. Detweiler BN, Kollmorgen LE, Umberham BA, Hedin RJ, Vassar BM. Risk of bias and methodological appraisal practices in systematic reviews published in anaesthetic journals: A meta-epidemiological study. Anaesthesia 2016; 71:955-968.
45. Roest AM, de Jonge P, Williams CD, de Vries YA, Schoevers RA, Turner EH. Reporting bias in clinical trials investigating the efficacy of secondgeneration antidepressants in the treatment of anxiety disorders: A report of 2 meta-analyses. JAMA Psychiatry 2015; 72:500-510.
46. Tzoulaki I, Siontis KC, Evangelou E, Ioannidis JPA. Bias in associations of emerging biomarkers with cardiovascular disease. JAMA Intern Med 2013; 173:664-671.
47. Grading quality of evidence and strength of recommendations. BMJ 2004; 328:1490-11490.
48. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-926.
49. Ansari MT, Tsertsvadze A, Moher D. Grading quality of evidence and strength of recommendations: A perspective. PLoSMed 2009; 6:e1000151.
50. Silagy CA, Middleton P, Hopewell S. Publishing protocols of systematic reviews: Comparing what was done to what was planned. JAMA 2002; 287:2831-2834.
51. Kirkham JJ, Altman DG, Williamson PR. Bias due to changes in specified outcomes during the systematic review process. PLoS One 2010; 5:e9810.
52. Davies S. The importance of PROSPERO to the National Institute for Health Research. Syst Rev 2012; 1:5.
53. Cohen E, Uleryk E, Jasuja M, Parkin PC. An absence of pediatric randomized controlled trials in general medical journals, 1985-2004. J Clin Epidemiol 2007; 60:118-123.
54. Caldwell PHY, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet 2004; 364:803-811.
55. Joseph PD, Craig JC, Caldwell PHY. Clinical trials in children. Br J Clin Pharmacol 2015; 79:357-369.
56. Cook DJ. Systematic reviews: Synthesis of best evidence for clinical decisions. Ann Intern Med 1997; 126:376-380.
57. Nissen T, Wayant C, Wahlstrom A, Sinnett P, Fugate C, Herrington J, Vassar M. Methodological quality, completeness of reporting and use of systematic reviews as evidence in clinical practice guidelines for paediatric overweight and obesity. Clin Obes 2017; 7:34-45.
58. Adler AJ, Taylor F, Martin N, Gottlieb S, Taylor RS, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev (12):2014; CD009217.
59. Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D. White-coat hypertension and cardiovascular events: A meta-analysis. J Hypertens 2016; 34:593-599.
60. Cai L, Wu Y, Cheskin LJ, Wilson RF, Wang Y. Effect of childhood obesity prevention programmes on blood lipids: A systematic review and meta-analysis. Obes Rev 2014; 15:933-944.
61. Chaudhry B, Wang J, Wu S, Maglione M, Mojica W, Roth E, et al. Systematic review: Impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med 2006; 144:742-752.
62. Gallagher CM, Meliker JR. Blood and urine cadmium, blood pressure, and hypertension: A systematic review and meta-analysis. Environ Health Perspect 2010; 118:1676-1684.
63. Garg AX, Adhikari NKJ, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: A systematic review. JAMA 2005; 293:1223-1238.
64. He FJ, MacGregor GA. Importance of salt in determining blood pressure in children: Meta-analysis of controlled trials. Hypertension 2006; 48:861-869.
65. Herder SD, Weber E, Winkemann A, Herder C, Morck H. Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents. Pediatr Nephrol 2010; 25:801-811.
66. Hupin D, Roche F, Gremeaux V, Chatard JC, Oriol M, Gaspoz JM, et al. Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged _60 years: A systematic review and meta-analysis. Br J Sports Med 2015; 49:1262-1267.
67. Juonala M, Magnussen CG, Venn A, Dwyer T, Burns TL, Davis PH, et al. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation 2010; 122:2514-2520.
68. Kelishadi R, Mirmoghtadaee P, Najafi H, Keikha M. Systematic review on the association of abdominal obesity in children and adolescents with cardio-metabolic risk factors. J Res Med Sci 2015; 20:294-307.
69. Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2012; 130:e714-e755.
70. Peacock WF 4th, Hilleman DE, Levy PD, Rhoney DH, Varon J. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am J Emerg Med 2012; 30:981-993.
71. Simonetti GD, Rizzi M, Donadini R, Bianchetti MG. Effects of antihypertensive drugs on blood pressure and proteinuria in childhood. J Hypertens 2007; 25:2370-2376.
72. Stergiou GS, Karpettas N, Kapoyiannis A, Stefanidis CJ, Vazeou A. Home blood pressure monitoring in children and adolescents: A systematic review. J Hypertens 2009; 27:1941-1947.
73. Thompson M, Dana T, Bougatsos C, Blazina I, Norris SL. Screening for hypertension in children and adolescents to prevent cardiovascular disease. Pediatrics 2013; 131:490-525.